Cook Tightens its Embrace of Women's Health
Women's health has long been among the most vexing markets for medical device companies, large and small. For major device companies, many industry executives largely attribute this problem to the fact that women's health is not a monolithic product market, but made up instead of many smaller niches. Other companies, however, take a contrarian approach. Cook Group Inc. is the most recent example, with its decision to create a new division dedicated exclusively to women's health.
You may also be interested in...
Brief summaries of recent product and company developments in the device industry, including J&J's shelving of Conor's CoStar Stent, new guidelines for treating atrial fibrilation, CMS' ruling on carotid stents, and Cyberonic's recent restructuring.
Zydus Cadila expects domestic sales to improve and the US generics business to grow in “mid to high” single digits during FY21 after both saw a coronavirus-related hit in Q1. Meanwhile, approvals for a few biologics are expected, its COVID-19 vaccine candidate has just entered Phase II studies and remdesivir launch looms.